共 15 条
[3]
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin
[J].
PHARMACOGENETICS,
2001, 11 (09)
:803-808
[4]
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele
[J].
PHARMACOGENETICS,
1999, 9 (01)
:71-80
[6]
Allelic discrimination using fluorogenic probes and the 5′ nuclease assay
[J].
GENETIC ANALYSIS-BIOMOLECULAR ENGINEERING,
1999, 14 (5-6)
:143-149
[8]
Genetic analysis of CYP2C9 polymorphism in a Japanese population
[J].
PHARMACOGENETICS,
1997, 7 (05)
:405-409
[9]
IMPAIRED (S)-WARFARIN METABOLISM CATALYZED BY THE R144C ALLELIC VARIANT OF CYP2C9
[J].
PHARMACOGENETICS,
1994, 4 (01)
:39-42
[10]
Genetic analysis of the human cytochrome P450 CYP2C9 locus
[J].
PHARMACOGENETICS,
1996, 6 (05)
:429-439